Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
APGA Annual ConferenceAPGA Annual Conference
Not Confirmed
Not Confirmed
20-23 July, 2025
Not Confirmed
Not Confirmed
24-25 July, 2025
BIO Asia-TaiwanBIO Asia-Taiwan
Not Confirmed
Not Confirmed
24-27 July, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
APGA Annual ConferenceAPGA Annual Conference
Industry Trade Show
Not Confirmed
20-23 July, 2025
Industry Trade Show
Not Confirmed
24-25 July, 2025
BIO Asia-TaiwanBIO Asia-Taiwan
Industry Trade Show
Not Confirmed
24-27 July, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/50-years-of-innovation-mikart-s-legacy-and-what-s-next-in-cdmo-excellence
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/cdmo-activity-tracker-veranova-carbogen-lead-adc-investments-axplora-polfa-tarchomin-famar-expand-european-footprint
07 Jul 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/07/07/3110960/0/en/UroGen-Announces-Completion-of-Enrollment-in-the-Phase-3-UTOPIA-Clinical-Trial-of-UGN-103-for-the-Treatment-of-Recurrent-Low-Grade-Intermediate-Risk-Non-Muscle-Invasive-Bladder-Can.html
14 Jun 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250610841284/en/U.S.-FDA-Approves-UroGens-ZUSDURI-mitomycin-for-Intravesical-Solution-as-the-First-and-Only-Medication-for-Recurrent-Low-Grade-Intermediate-Risk-Non-Muscle-Invasive-Bladder-Cancer-LG-IR-NMIBC
06 Jun 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250606792691/en/UroGen-Pharma-Announces-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635c4
02 Jun 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250602781070/en/UroGen-Presents-uTRACT-Registry-at-ASCO-2025-Annual-Meeting-Designed-to-Study-Real-World-Use-of-JELMYTO-in-Low-Grade-Upper-Tract-Urothelial-Cancer
02 Jun 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250602560792/en/UroGen-Announces-Data-at-ASCO-2025-Annual-Meeting-on-UGN-102-an-Investigational-Treatment-for-Recurrent-Low-Grade-Intermediate-Risk-Non-Muscle-Invasive-Bladder-Cancer-LG-IR-NMIBC
27 May 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250527694477/en/UroGen-Pharma-to-Present-at-TD-Cowen-6th-Annual-Oncology-Innovation-Summit-Insights-for-ASCO-EHA
ABOUT THIS PAGE